News

Fast Forward, LLC, Seeking Proposals in Early Stage Drug Development for MS

May 07, 2009
Fast Forward, LLC, a subsidiary of the National MS Society (USA), and EMD Serono, Inc., an affiliate of Merck KGaA, announced a commitment of $3 million to support innovative early-stage projects directed towards the development of therapies to prevent, treat, or reverse nervous system damage in multiple sclerosis. This initial Request for Proposals marks the beginning of a multi-year collaboration to develop new MS therapies, for which Merck KGaA will provide up to $19 million.

Fast Forward, LLC and Provid Pharmaceuticals Announce Partnership for Development of PV-267, A Unique Compound Intended to Redirect the Abnormal Immune Response In Multiple Sclerosis

May 05, 2009
Provid Pharmaceuticals, Inc, a drug discovery company, and Fast Forward, LLC, the National Multiple Sclerosis Society’s subsidiary devoted to bridging the gap between research and drug development, today announced a partnership to support Provid’s preclinical studies of PV-267. This novel compound is designed to redirect the abnormal immune response associated with multiple sclerosis (MS).

Fast Forward, LLC and EMD Serono Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis

Mar 18, 2009
Fast Forward and EMD Serono agree to work together to speed research development on a select group of high potential MS research projects with support of up to $19 million in funding

National Multiple Sclerosis Society Commends President Obama’s Initial Steps in Removing the Bans on Embryonic Stem Cell Research

Mar 08, 2009
The National Multiple Sclerosis Society is a driving force in creating a world free of MS. To advance this goal, the Society continues to seek ways to prevent, slow the progression or repair the effects of MS. One channel is by supporting scientifically meritorious medical research, including research using human cells. This is done in accordance with federal, state and local laws and with adherence to the strictest ethical and procedural guidelines. For the past eight years, federal policies have impeded these efforts by severely limiting the number of approved embryonic stem cell lines that could be used in federally funded research and prohibiting the donation of unused embryos for research purposes by people utilizing the services of in vitro fertilization clinics.

MOVE IT! Join the Movement to End Multiple Sclerosis Now - MS Awareness Week March 2-8, 2009

Mar 02, 2009
MS Awareness Week March 2 – 8 is the time for the nation to go orange and Move It to end multiple sclerosis, a disease where someone is newly diagnosed each hour. Supported by a Congressional Resolution, this year MS Awareness Week and the state of MS research aptly coincide: Move It to create a world free of MS.